By the end of this year, an innovative, easy and low-cost approach to screening for eye diseases - such as diabetic retinopathy and glaucoma - will be available to every European ophthalmologist. MONA.health, a spin-off of Flemish research and technology institute VITO and KU Leuven, has gained the confidence of Belgian investors to make this technique ready for commercialisation.
|